Touch and Tell
by American Printing House for the Blind
Last verified June 15, 2026 · classified May 23, 2026
What it is
Summary
AI-generated from vendor-published content · May 23, 2026
Touch and Tell is a three-volume set of tactile picture books designed to build early literacy and pre-braille readiness skills in young children who are blind or have low vision. Each page features raised tactile graphics that kids explore by touch, helping them develop the finger sensitivity and tactile discrimination needed before formal braille instruction begins. Parents or early intervention specialists read the print text aloud while the child engages with the tactile images — making this a shared-reading tool rather than an independent one. Note that APH has discontinued this product, so availability is limited to existing stock or secondary sources.
Quick Facts Catalog facts · auto-generated
- AT Act lending
- Out of pocket
- School district
What Setup Looks Like
- Out of the box
Open the books and explore the tactile pages with a child — no setup required. - With professional help
A teacher of the visually impaired (TVI) or early intervention specialist can integrate these books into a structured pre-braille curriculum and guide tactile exploration techniques.
Getting it
Try Before You Buy
Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
Wondering how equipment like this gets paid for? See the official funding programs in your state.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from American Printing House for the Blind — view on vendor site; last verified June 15, 2026.
Classification & description AI-generated from vendor-published content on May 23, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.